Modular electrochemical cell for screening tasks. Credit: Fraunhofer IMM/Tobias Hang Electrochemical processes like water electrolysis will become increasingly important in the future in light of ...

Standardizing cell therapy production will require a combination of AI, automation, and innovative bioprocessing technologies.

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, producing cell aggregates in bioreactors is highly complex and cost-intensive.

As industries accelerate toward automation, conversations typically center on artificial intelligence, machine learning and the integration of robotics. However, one foundational concept is emerging ...